Description
Vaccines are extremely important public health interventions, but vaccine science and vaccine confidence are challenged. The vaccine debate is becoming polarised and politicised. This hampers vaccine science and fuels vaccine hesitancy. New knowledge about the broader immunomodulatory effects of vaccines and their potential to strengthen overall immune capacity is not sufficiently considered but may potentially strengthen vaccine confidence. Epidemiological studies have revealed that live vaccines can protect more broadly against unrelated infections. Supportive immunological data show that live vaccines can strengthen the innate immune system and thereby reduce the risk of other infections. Recent studies indicate that these effects extend to beneficial effects against non-communicable diseases and may reduce all-cause mortality in both children and adults.
VAC360 aims to unite dispersed research groups working on broader immunomodulatory vaccine effects, immune training and vaccine hesitancy across Europe. Including a broad range of stakeholders, the objectives include to (i) establish common protocols and platforms for multi-country studies of the broader and overall health effects of vaccines, (ii) provide biomarkers, (iii) map the monitoring of broader vaccine effects across Europe, (iv) create a collaborative European network to empower young researchers to study vaccines, (v) depolarise the vaccine debate, and (vi) establish a structured dialogue with vaccine policy-makers to ensure that scientific evidence on broader vaccine effects informs vaccination policies and strengthens trust through transparent, evidence-based governance – with the overriding aim to achieve impactful vaccination programs with optimised timing and scheduling of vaccines across the lifespan.
Action keywords
Vaccines - Immunomodulatory effects - Sex-differences - Overall health - Vaccination programs
Management Committee
| Country | MC Member |
|---|---|
| Bulgaria | |
| Cyprus | |
| Cyprus | |
| Denmark | |
| Estonia | |
| Ireland | |
| North Macedonia | |
| Poland | |
| Poland | |
| Spain | |
| Switzerland | |
| Türkiye |
Main Contacts
Action Contacts
COST Staff
Working Groups
| Number | Title | Leader |
|---|---|---|
| 1 | Outcomes and Gaps in the Knowledge: Platforms for Testing Broader Vaccine Effects | TBA |
| 2 | Biomarkers of Broader Immunomodulatory Effects of Vaccines | TBA |
| 3 | Vaccine-Associated Negative and Positive Events Across-Europe | TBA |
| 4 | Building Capacity for Transparent and Depolarised Vaccine Communication | TBA |
| 5 | Translating Evidence on Broader Vaccine Effects into Policy Dialogue | TBA |
Express your interest to join any of the working groups by applying below.
It is required to have an e-COST profile to submit your application. If needed, create it first and then click 'Apply'.
Apply